相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton's Tyrosine Kinase (BTK)
Scott H. Watterson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial
Tsutomu Takeuchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models
Philipp Haselmayer et al.
JOURNAL OF IMMUNOLOGY (2019)
Bruton's tyrosine kinase (Btk) inhibitor tirabrutinib suppresses osteoclastic bone resorption
Yuko Ariza et al.
BONE REPORTS (2019)
Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials
Yoshiya Tanaka et al.
MODERN RHEUMATOLOGY (2018)
ITK and RLK Inhibitor PRN694 Improves Skin Disease in Two Mouse Models of Psoriasis
Jessica M. Fuhriman et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton's Tyrosine Kinase Inhibitor in Early Clinical Development
James J. y Crawford et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
TAS05567, a Novel Potent and Selective Spleen Tyrosine Kinase Inhibitor, Abrogates Immunoglobulin-Mediated Autoimmune and Allergic Reactions in Rodent Models
Hiroaki Hayashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Use of acalabrutinib in patients with mantle cell lymphoma
Farrukh T. Awan et al.
EXPERT REVIEW OF HEMATOLOGY (2018)
Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis
Yahui Grace Chiu et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
Biologic therapies and bone loss in rheumatoid arthritis
C. A. F. Zerbini et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Pathogenetic insights from the treatment of rheumatoid arthritis
Iain B. McInnes et al.
LANCET (2017)
Investigations on the molecular mode of action of the novel immunostimulator ZelNate: Activation of the cGAS-STING pathway in mammalian cells
Thomas Ilg
MOLECULAR IMMUNOLOGY (2017)
Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care
Kathleen M. Gillooly et al.
PLOS ONE (2017)
Short single-stranded DNA degradation products augment the activation of Toll-like receptor 9
Jelka Pohar et al.
NATURE COMMUNICATIONS (2017)
Increased risk of vertebral fracture in patients with rheumatoid arthritis A meta-analysis
Bin Chen et al.
MEDICINE (2016)
Production of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid Arthritis
Nida Meednu et al.
ARTHRITIS & RHEUMATOLOGY (2016)
HM71224, a novel Bruton's tyrosine kinase inhibitor, suppresses B cell and monocyte activation and ameliorates arthritis in a mouse model: a potential drug for rheumatoid arthritis
Jin Kyun Park et al.
ARTHRITIS RESEARCH & THERAPY (2016)
A Small Molecule Inhibitor of ITK and RLK Impairs Th1 Differentiation and Prevents Colitis Disease Progression
Hyoung-Soo Cho et al.
JOURNAL OF IMMUNOLOGY (2015)
Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis
Sarah E. Headland et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Tofacitinib versus Methotrexate in Rheumatoid Arthritis
Eun Bong Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans
Erica K. Evans et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK
Casimiro Castillejo-Lopez et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
C5a-regulated CCAAT/Enhancer-binding Proteins β and δ Are Essential in Fcγ Receptor-mediated Inflammatory Cytokine and Chemokine Production in Macrophages
Chunguang Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment
Georg Schett et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
RN486, a Selective Bruton's Tyrosine Kinase Inhibitor, Abrogates Immune Hypersensitivity Responses and Arthritis in Rodents
Daigen Xu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
An overview on the genetic of rheumatoid arthritis: A never-ending story
Carlo Perricone et al.
AUTOIMMUNITY REVIEWS (2011)
Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys
Michael S. Ominsky et al.
BONE (2011)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells
Betty Y. Chang et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis
Beatrix Bartok et al.
IMMUNOLOGICAL REVIEWS (2010)
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
Lee A. Honigberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Chemical target and pathway toxicity mechanisms defined in primary human cell systems
Ellen L. Berg et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2010)
Tyrosine kinases as targets for the treatment of rheumatoid arthritis
Christina D'Aura Swanson et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals
Masahiro Shinohara et al.
CELL (2008)
Dual functions of Bruton's tyrosine kinase and tec kinase during Fcγ receptor-induced signaling and phagocytosis
Jenny Jongstra-Bilen et al.
JOURNAL OF IMMUNOLOGY (2008)
Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation
Peter R. Wilker et al.
NATURE IMMUNOLOGY (2008)
Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs
M. Saito et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Amelioration of bone loss in collagen-induced arthritis by neutralizing anti-RANKL monoclonal antibody
Seiji Kamijo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
A new model for an etiology of rheumatoid arthritis
L Klareskog et al.
ARTHRITIS AND RHEUMATISM (2006)
Autoamplification of NFATc1 expression determines its essential role in bone homeostasis
M Asagiri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Chemokines and chemokine receptors in rheumatoid arthritis
Z Szekanecz et al.
SEMINARS IN IMMUNOLOGY (2003)
Regulation of B-cell fate by antigen-receptor signals
H Niiro et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase
WN Khan
IMMUNOLOGIC RESEARCH (2001)
Signaling network of the Btk family kinases
Y Qiu et al.
ONCOGENE (2000)
Induction and suppression of collagen-induced arthritis is dependent on distinct Fcγ receptors
S Kleinau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
